Peregrine Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-39,608
| Closed | -$3.26M | – | 348 |
|
|
2022
Q1 | $3.26M | Sell |
39,608
-2,851
| -7% | -$234K | 0.08% | 252 |
|
|
2021
Q4 | $6.23M | Buy |
42,459
+1,200
| +3% | +$176K | 0.12% | 242 |
|
|
2021
Q3 | $7.3M | Sell |
41,259
-23,902
| -37% | -$4.23M | 0.15% | 235 |
|
|
2021
Q2 | $10.5M | Buy |
65,161
+4,774
| +8% | +$771K | 0.19% | 228 |
|
|
2021
Q1 | $10.3M | Buy |
+60,387
| New | +$10.3M | 0.19% | 229 |
|